Literature DB >> 114488

Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine.

R H Kenyon, R A Kishimoto, W C Hall.   

Abstract

Guinea pigs were inoculated with Rocky Mountain spotted fever by the aerosol, conjunctival, subcutaneous, intragastric, and intranasal routes. Rickettsial infection was produced by all routes except intragastric. All animals with clinical signs of disease developed agglutinating antibody, and most developed a cell-mediated immune response. Disease produced by all experimental routes (except intragastric) was indistinguishable. The tissue culture-derived inactivated vaccine produced in this laboratory protected guinea pigs against an aerosol challenge.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114488      PMCID: PMC414484          DOI: 10.1128/iai.25.2.580-582.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Factors affecting the growth of rickettsias of the spotted fever group in fertile hens' eggs.

Authors:  H G STOENNER; D B LACKMAN; E J BELL
Journal:  J Infect Dis       Date:  1962 Mar-Apr       Impact factor: 5.226

2.  Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin.

Authors:  M S Ascher; C N Oster; P I Harber; R H Kenyon; C E Pedersen
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

3.  Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.

Authors:  R A Kishimoto; G T Burger
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

5.  Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.

Authors:  H L DuPont; R B Hornick; A T Dawkins; G G Heiner; I B Fabrikant; C L Wisseman; T E Woodward
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

6.  The pathogenesis of Rocky Mountain spotted fever in monkeys, infected by inhalation.

Authors:  G L Wolf; C R Cole; H N Carlisle; S Saslaw
Journal:  Arch Pathol       Date:  1967-11

7.  Aerosol infection of monkeys with Rickettsia rickettsii.

Authors:  S Saslaw; H N Carlisle
Journal:  Bacteriol Rev       Date:  1966-09

8.  Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission.

Authors:  C N Oster; D S Burke; R H Kenyon; M S Ascher; P Harber; C E Pedersen
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

9.  Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture.

Authors:  R H Kenyon; W M Acree; G G Wright; F W Melchior
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

10.  In vitro guinea pig leukocyte reactions to Rickettsia rickettsii.

Authors:  R H Kenyon; M S Ascher; R A Kishimoto; C E Pedersen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more
  5 in total

1.  Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B.

Authors:  Yvonne Gar-Yun Chan; Sean Phillip Riley; Emily Chen; Juan José Martinez
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

2.  Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys.

Authors:  J C Gonder; R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

Review 3.  The realities of biodefense vaccines against Rickettsia.

Authors:  David H Walker
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

4.  Rocky Mountain spotted fever vaccine in an animal model.

Authors:  J D Folds; D H Walker; B C Hegarty; D Banasiak; J V Lange
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Serological Evidence of Exposure to Spotted Fever Group and Typhus Group Rickettsiae in Australian Wildlife Rehabilitators.

Authors:  Karen O Mathews; David Phalen; Jacqueline M Norris; John Stenos; Jenny-Ann Toribio; Nicholas Wood; Stephen Graves; Paul A Sheehy; Chelsea Nguyen; Katrina L Bosward
Journal:  Pathogens       Date:  2021-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.